Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 8.64B P/E - EPS this Y 12.60% Ern Qtrly Grth -
Income -132M Forward P/E 17.76 EPS next Y 17.00% 50D Avg Chg 3.00%
Sales 3.96B PEG 1.15 EPS past 5Y -5.60% 200D Avg Chg 12.00%
Dividend 1.00% Price/Book 2.33 EPS next 5Y 14.10% 52W High Chg -6.00%
Recommedations 2.20 Quick Ratio 0.79 Shares Outstanding 207.36M 52W Low Chg 54.00%
Insider Own 0.60% ROA 2.41% Shares Float 205.84M Beta 1.00
Inst Own 105.85% ROE -3.72% Shares Shorted/Prior 10.06M/10.79M Price 40.67
Gross Margin 52.71% Profit Margin -3.33% Avg. Volume 1,661,143 Target Price 37.04
Oper. Margin 7.02% Earnings Date May 1 Volume 1,702,119 Change -1.69%
About DENTSPLY SIRONA Inc.

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina

DENTSPLY SIRONA Inc. News
03/27/24 S&P 500 to add 3M and GE spin-offs, replacing VF and Dentsply Sirona
03/27/24 GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600
03/23/24 DENTSPLY SIRONA (NASDAQ:XRAY) Has Announced That It Will Be Increasing Its Dividend To $0.16
03/21/24 Here's Why Dentsply International (XRAY) is a Strong Momentum Stock
03/19/24 Why Dentsply International (XRAY) is a Top Value Stock for the Long-Term
03/05/24 DENTSPLY SIRONA (NASDAQ:XRAY) Will Pay A Dividend Of $0.14
03/02/24 DENTSPLY SIRONA Full Year 2023 Earnings: Beats Expectations
03/01/24 DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Q4 2023 Earnings Call Transcript
03/01/24 Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
02/29/24 Dentsply (XRAY) Reports Q4 Earnings: What Key Metrics Have to Say
02/29/24 DENTSPLY SIRONA (XRAY) Q4 Earnings Beat Estimates, Sales Up Y/Y
02/29/24 Dentsply Sirona Inc (XRAY) Reports Modest Revenue Growth Amidst Net Loss for FY23
02/29/24 Dentsply International (XRAY) Q4 Earnings and Revenues Beat Estimates
02/29/24 Dentsply Sirona Announces Retirement of Eric K. Brandt from the Board of Directors
02/29/24 Dentsply Sirona Reports Fourth Quarter and Full Year 2023 Results, Provides Full Year 2024 Outlook, Raises Dividend
02/26/24 What's in Store for DENTSPLY SIRONA (XRAY) in Q4 Earnings?
02/26/24 Stay Ahead of the Game With Dentsply (XRAY) Q4 Earnings: Wall Street's Insights on Key Metrics
02/07/24 Will Dentsply (XRAY) Beat Estimates Again in Its Next Earnings Report?
01/29/24 Dentsply Sirona to Host Fourth Quarter and Full Year 2023 Conference Call on February 29th
01/23/24 Top 15 Countries for Dental Tourism
XRAY Chatroom

User Image DonCorleone77 Posted - 14 hours ago

$XRAY $FOXF Dentsply Sirona to replace Fox Factory in S&P 400 at open on 4/3

User Image DonCorleone77 Posted - 14 hours ago

$GEV $XRAY GE Vernova to replace Dentsply Sirona in S&P 500 at open on 4/2 GE Vernova (GEV) will be added to the S&P 500 effective prior to the open of trading on Tuesday, April 2, replacing Dentsply Sirona (XRAY), which will be moved to the S&P MidCap 400 effective prior to the open of trading on Wednesday, April 3.

User Image smartkarma Posted - 5 days ago

$XRAY | Dentsply International (XRAY US): Sombre Growth Outlook and Pricey Valuation "​Dentsply International expects just 1% organic revenue growth in 2024 due to challenging macro environment. In terms of every valuation metrics, Dentsply is overpriced compared to its peers." - Tina Banerjee Key Points: * Dentsply International (XRAY US) guided for 2024 revenue of $3.96–4.02B, flat to up 1.5% on an organic basis and 12% growth in 2024 EPS at midpoint. * The macro environment continues to be challenging. The company anticipates the ongoing softness in imaging will continue in 2024. Cost savings will support the bottom-line growth. * In terms of every valuation metrics, Dentsply is overpriced compared to its U.S.-listed peers. Strong balance sheet, accelerating dividend, and buyback do not justify the pricey valuation. Read more: https://www.smartkarma.com/insights/dentsply-international-xray-us-sombre-growth-outlook-and-pricey-valuation

User Image EmmaRespond Posted - 1 week ago

DENTSPLY SIRONA Inc. - A Promising Investment Opportunity with $XRAY Ticker http://dlvr.it/T4LF7s

User Image EmmaRespond Posted - 1 week ago

DENTSPLY SIRONA Inc. - A Promising Investment Opportunity with $XRAY Ticker http://dlvr.it/T4LBsq

User Image noeljefe Posted - 2 weeks ago

$BIOL Biolase would quickly be a profitable business unit (acquisition ) under any of these companies in the dental industry, by simply eliminating bloated departments that could be absorbed into current operations. Keep R&D and support. SG&A are all susceptible: $XRAY $ALGN $MMM $STMN $DHR Dentsply Sirona: Dentsply Sirona is one of the largest manufacturers of dental products and technologies worldwide. Henry Schein: Henry Schein is a leading distributor of healthcare products and services, including dental supplies, equipment, and software solutions. Align Technology: Align Technology is known for its Invisalign system. Danaher Corporation (including KaVo Kerr): Danaher is a multinational conglomerate with a significant presence in the dental industry through its various subsidiaries. 3M Oral Care: 3M Oral Care offers a wide range of dental products, including restorative materials, preventive products, and oral care accessories.

User Image epsguid Posted - 02/29/24

$XRAY reported earnings of $0.44, consensus was $0.43, Earnings Whisper was $0.46 via @eWhispers #whispermiss http://eps.sh/d/xray

User Image DonCorleone77 Posted - 02/29/24

$XRAY Dentsply Sirona sees FY24 adjusted EPS $2.00-$2.10, consensus $2.05 Sees FY24 organic sales flat to up 1.5%, consensus $4B.

User Image DonCorleone77 Posted - 02/29/24

$XRAY Dentsply Sirona reports Q4 adjusted EPS 44c, consensus 43c Reports Q4 revenue $1.01B, consensus $976.87M. "We delivered on our outlook with three of our four segments posting year-over-year growth in the fourth quarter and full year 2023," said Simon Campion, President and Chief Executive Officer. "Dentsply Sirona's transformation is taking shape, and while there is more work ahead, we expect that 2024 will be an inflection point for improved profitability and adjusted earnings per share growth. We maintain our conviction that we are on the right path to deliver meaningful value over the long term."

User Image Stock_Titan Posted - 02/29/24

$XRAY Dentsply Sirona Reports Fourth Quarter and Full Year 2023 Results, Provides Full Year 2024 Outlook, Raises Dividend https://www.stocktitan.net/news/XRAY/dentsply-sirona-reports-fourth-quarter-and-full-year-2023-results-9ytzy7b8zqyd.html

User Image DonCorleone77 Posted - 4 weeks ago

$BBY $PZZA $BBWI $XRAY $SIX Notable companies reporting before tomorrow's open Notable companies reporting before tomorrow's open, with earnings consensus, include Best Buy (BBY), consensus $2.51... Hormel Foods (HRL), consensus 34c... Bath & Body Works (BBWI), consensus $1.87... Birkenstock (BIRK), consensus 10c... Dentsply Sirona (XRAY), consensus 43c... Papa John's (PZZA), consensus 72c... Six Flags (SIX), consensus 27c.

User Image TickerDD_com Posted - 1 month ago

From 2/16/2024, looking back across 22 Month-Ends for XRAY, Percentage Change of Average Monthly Price had More Positives (55%) while Percentage Change of Average Monthly Volume had More Positives (95%) $XRAY #XRAY #XRAYStock #TickerDD #XRAYPrice https://www.youtube.com/watch?v=IkwC3q_OAT8

User Image swingingtech Posted - 1 month ago

$XHE $ZBH $XRAY https://wallstreetwaves.com/spdr-sp-health-care-equipment-etf-insider-buying-index-registering-10-1/

User Image RiskVsReward Posted - 1 month ago

Hey guys check out $XRAY πŸ“’πŸ“’ This has potential depending on your style.

User Image Aigner_Andreas Posted - 1 month ago

TF SELL $XRAY at 34.19 : 34.37 MidCap -6% Shp 1.04 S 7.53 N 0.78 RSI 43.18% SRSI 0% ADXR 30.4 #stocks #trading #finance #market

User Image Trader_Ty Posted - 2 months ago

$XRAY Swing

User Image ChartMill Posted - 2 months ago

Good technicals, but also a nice setup pattern forming for $JPM, $CTSH, $XRAY and $ARCC. Now part of our top breakout selection. https://www.chartmill.com/stock/stock-screener?sid=202&f=v1_50b500,atrpct_a_1,sl_ta_7_X,sl_se_7_X,p_pg20,exch_us&s=vol50&v=3&utm_source=High_Volume_Breakout_Setups&utm_medium=stocktwits&utm_campaign=screen

User Image UltraAlgo Posted - 2 months ago

$XRAY Sell Rating from 12 signals, 15-min ticks πŸš€ Chart by UltraAlgo https://i.redd.it/sd73k5hwxzcc1.png

User Image StockInvest_us Posted - 2 months ago

Signal alert: $XRAY - Overvalued https://stockinvest.us/l/fUgXknFjuj

User Image Trader_Ty Posted - 2 months ago

$XRAY

User Image StockAutomatePro Posted - 2 months ago

$XRAY Not a bad time to invest chart shows potential growth. We alerted the BUY signal at $35.31 and we were able to close this one with profit at $37.39πŸ€™

User Image TrendyChart Posted - 2 months ago

$XRAY When life gives you lemons, make lemonade. But these stocks are making a lemonade stand and turning a profit! πŸ‹πŸ’Ή https://share.trendspider.com/chart/XRAY/804378og8lz

User Image Yaloo159 Posted - 2 months ago

$XRAY

User Image tickeron Posted - 2 months ago

How does this make you feel? $XRAY RSI Indicator left the overbought zone. View odds of downtrend. https://srnk.us/go/4965224

User Image StockAutomatePro Posted - 2 months ago

$XRAY Good news for investors chart analysis shows upward momentum. We alerted the BUY signal at $35.2 and we were able to close this one with profit at $36.53 πŸ’–

User Image shortvolumes Posted - 2 months ago

The short sale volume (not short interest) for $XRAY on 2024-01-08 is 44%. http://shortvolumes.com/?t=XRAY via @shortvolumes

User Image EarningsInsider Posted - 2 months ago

$XRAY updates FY 2023 guidance to 1.800-1.850 EPS and revenue guidance to $3.9 billion-$3.9 billion. www.marketbeat.com/stocks/NASDAQ/XRAY/

User Image EarningsInsider Posted - 2 months ago

$XRAY updates FY23 guidance to $1.80-1.85 EPS. www.marketbeat.com/stocks/NASDAQ/XRAY/earnings/

User Image Last10K Posted - 2 months ago

$XRAY just filed with the SEC a Earnings Release, a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/XRAY/0000818479-24-000004.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=XRAY

User Image risenhoover Posted - 2 months ago

$XRAY / DENTSPLY SIRONA files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 January 9, 2024 Date of Report (Date of earliest event reported) DENTSPLY SIRONA In https://fintel.io/doc/sec-dentsply-sirona-inc-818479-8k-2024-january-09-19731-3523?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

Analyst Ratings
Barrington Research Outperform Mar 1, 24
Needham Buy Feb 29, 24
Leerink Partners Outperform Feb 26, 24
Piper Sandler Neutral Jan 12, 24
Needham Buy Jan 9, 24
Needham Buy Nov 16, 23
Stifel Hold Nov 13, 23
William Blair Outperform Nov 10, 23
Goldman Sachs Neutral Nov 7, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Deese Willie A Director Director May 23 Option 38.02 6,900 262,338 29,926 05/25/22
BRANDT ERIC Director Director May 03 Option 38.02 6,900 262,338 42,055 05/04/22
BRANDT ERIC Director Director May 03 Sell 39.71 6,900 273,999 35,155 05/04/22
LUNGER FRANCIS J Director Director Mar 05 Option 38.57 7,600 293,132 32,864 03/05/21
LUNGER FRANCIS J Director Director Mar 05 Sell 59.05 7,600 448,780 25,264 03/05/21